An official website of the United States government
Here's how you know
Official websites use .mil
A
.mil
website belongs to an official U.S. Department of Defense organization in the United States.
Secure .mil websites use HTTPS
A
lock (
lock
)
or
https://
means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.
Skip to main content (Press Enter).
Toggle navigation
JPEO-CBRND
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense
JPEO-CBRND
Search Joint Program Executive Office for Chemical, Biological Defense (JPEO-CBRND):
Search
Search
Search Joint Program Executive Office for Chemical, Biological Defense (JPEO-CBRND):
Search
Home
About
Leadership
Joint Project Managers & Joint Project Leads
Our Story
Resources
Media
News
Photography
Work With Us
JETT - Joint Enterprise Technology Tool
SPARK
Careers
Contact
News
1
2
3
4
Results:
Archive:
2022
Senior Response Leaders Shown Latest Chemical, Biological Defense Technology Available for Disaster Response
December 22, 2022
— A group of senior leaders responsible for carrying out national disasters responses were recently shown the latest capabilities for responding to chemical, biological, radiological and nuclear (CBRN) events. On November 30, personnel from the Joint Program Executive Office for CBRN Defense along with the Air Force CBRN Defense Systems Branch and the Uniformed Services University’s 4DBio Program demonstrated current and future CBRN defense capabilities to a senior leadership team comprised of representatives from the White House’s Office of Science and Technology Policy, the National Security Council’s Office for Resilience and Response, the Defense Threat Reduction Agency, the Federal Emergency Management Agency (FEMA), and additional domestic emergency response organizations...
MORE
DoD Funds Production of More Life-Saving Medicine for Use After Nerve Agent Exposure
December 22, 2022
— The Defense Department's office responsible for acquiring medical countermeasures against chemical, biological, radiological and nuclear (CBRN) threats has awarded an agreement for the production of more life-saving nerve agent exposure treatments. The Joint Project Manager for CBRN Medical (JPM CBRN Medical) awarded a follow-on other transaction authority production agreement to Rafa Laboratories, Ltd. (Rafa) to manufacture and deliver 10mg midazolam injection autoinjectors to the Joint Force beginning December 2022. The midazolam injection autoinjector is indicated to treat prolonged seizures in adults, which can occur after exposure to a nerve agent. This new Advanced Anticonvulsant System (AAS) improves upon, and will eventually replace, the currently fielded Convulsant Antidote for Nerve Agent (CANA) diazepam autoinjector. Fielding the midazolam injection autoinjector gives the warfighter and the Nation access to a life-saving medical countermeasure in CBRN environments...
MORE
3d CR Troopers test new protection garments
December 14, 2022
— 3d Cavalry Regiment Troopers took part in testing new Chemical, Biological, Radiation, and Nuclear protection garments here Dec. 5-8. The Chemical, Biological Duty Uniform (CBDU), is still in the testing phase but is projected to replace the Joint Service Lightweight Integrated Suit Technology (JSLIST) and fielded in the next few years. Features of the new CBDU improve on the fitting, comfort, weight, temperature regulation, and CBRN protection – much needed upgrades from the JSLIST Troopers are currently fielded, according to Tiffany Swidrak, a test support analyst for the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense – General Purpose team...
MORE
NSWC Crane employee serves public health overseeing $900M portfolio as U.S. expands vaccine and therapeutic manufacturing supply chain
December 14, 2022
— A Naval Surface Warfare Center, Crane Division (NSWC Crane) employee is serving on a detail overseeing a $900 million portfolio to expand the U.S. vaccine and therapeutic manufacturing supply chain. Over the past two years, these investments and partnerships with industry have developed into the construction of new manufacturing facilities across the country to develop future vaccine and therapeutic capabilities. The JPEO-CBRND and the Army Contracting Command were leveraged to assist the Biomedical Advanced Research and Development Authority, which is an office in the U.S. Department of Health and Human Services, who were tasked in 2020 to ensure that every COVID-19 vaccine, therapeutic, and test kit were bought, packaged, and delivered to the Nation. The JPEO-CBRND has a special Joint Assisted Acquisition (JA2) team, established by the May 2021 memorandum of understanding between DoD and HHS, which supports the continued contracting and acquisition expertise needed for the Nation’s ongoing mission to fight the coronavirus, including partnerships with the Federal COVID-19 Response interagency team, academia and the American industrial base...
MORE
Joint Teams Conduct First F-22 In-Flight Tests for Aircrew CBRN Protection
November 3, 2022
— The U.S. Air Force conducted the first in-flight vapor purge tests on the F-22 Raptor with the support of the 422nd Test and Evaluation Squadron and the 59th Test Squadron on Nellis Air Force Base from Oct. 13-21, 2022...
MORE
U.S. and Israeli Collaboration at 20th Shoresh Meeting Promotes Advancement of CBRN Medical Countermeasure Development
October 20, 2022
— This past September, representatives from the U.S. Defense Department (DoD) participated in the 20th biennial Shoresh Military Medicine Conference in Rockville, Maryland. Shoresh, co-hosted by the Israeli Defense Force (IDF) and the U.S. Army Medical Research and Development Command (USAMRDC), is a collaborative gathering of DoD and IDF medical personnel that covers medical, chemical, biological defense, and military medicine topics. “You all save lives,” said Dr. Brian Lein, the Defense Health Agency’s assistant director for healthcare administration. “The things we talked about four or six years ago are now saving American and Israeli lives, based on innovation first developed here.”...
MORE
JPEO-CBRND Announces Openings for Acquisition Soldiers
October 17, 2022
— For Army acquisition officers with the rank of captain through colonel set to have a permanent change of station in summer 2023, the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) has announced four opportunities to serve at JPEO-CBRND during this year’s Assignment Interactive Module version 2, or “AIM 2.”...
MORE
AFLCMC, JPEO collaborate to set up SAL capabilities demo during Toxic Pineapple II
October 11, 2022
— The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense recently collaborated alongside the Air Force Life Cycle Management Center Air Force CBRN Defense Systems Branch and the 15th Wing to deliver a standalone large shelter during exercise Toxic Pineapple II at Hickam Air Force Base, Aug. 29 to Sept. 1...
MORE
AFLCMC, JPEO collaborate to set up SAL capabilities demo during Toxic Pineapple II
October 11, 2022
— The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense recently collaborated alongside the Air Force Life Cycle Management Center Air Force CBRN Defense Systems Branch and the 15th Wing to deliver a standalone large shelter during exercise Toxic Pineapple II at Hickam Air Force Base, Aug. 29 to Sept. 1...
MORE
Beacon of Light: NSWC Philadelphia Division Employee Awarded Armed Forces Civilian Medal for Pandemic Support
September 28, 2022
— Naval Surface Warfare Center, Philadelphia Division employee Andrew C. Lucas was awarded the Armed Forces Civilian Service Medal (AFCSM) for participating on the Joint Assisted Acquisition (JA2) program that provided the acquisition and technical expertise needed to transition and accelerate the U.S. Government’s ongoing COVID-19 response and pandemic preparedness. The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense’s Joint Assisted Acquisition (JPEO-CBRND) JA2 team was established to serve as part of the U.S. government response, working at the forefront of ensuring that global health goals were supported, and that the international community was well-equipped to combat this pandemic...
MORE
1
2
3
4
News Search
News Archive - Search by Year and Month
2024 (34)
2023 (36)
2022 (31)
December (4)
November (1)
October (4)
September (5)
August (3)
July (3)
June (1)
May (1)
March (2)
February (2)
January (5)
2021 (37)
2020 (15)
2019 (11)
2018 (5)
2017 (9)
2016 (1)
JPEO-CBRND Press Kit
Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.
JPEO-CBRND Public Affairs Office
The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.